ストックスクリーナーアプリを入手
60.58
0.59%
-0.36
アフターアワーズ：
60.58
前日終値:
$60.94
開ける：
$60.71
24時間の取引高:
418.40K
Relative Volume:
1.11
時価総額：
$2.10B
収益：
-
当期純損益:
$-91.00M
株価収益率:
-16.51
EPS:
-3.67
ネットキャッシュフロー:
$-74.38M
1週間 パフォーマンス:
+4.83%
1か月 パフォーマンス:
+10.15%
6か月 パフォーマンス:
+5.45%
1年 パフォーマンス:
+35.95%
1日の値動き範囲:
$59.52
$61.73
1週間の範囲:
$57.42
$62.00
52週間の値動き範囲:
$30.82
$68.73
Disc Medicine Inc Stock (IRON) Company Profile
名前
Disc Medicine Inc
セクター
電話
(617) 674-9274
住所
321 ARSENAL STREET, SUITE 101, WATERTOWN
IRON を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
60.58 | 2.10B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-21 | 開始されました | Truist | Buy |
| 2025-07-03 | 再開されました | Morgan Stanley | Overweight |
| 2025-06-11 | 再開されました | Raymond James | Strong Buy |
| 2025-02-27 | 開始されました | TD Cowen | Buy |
| 2024-11-05 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | 開始されました | Jefferies | Buy |
| 2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-08-22 | 開始されました | Wells Fargo | Overweight |
| 2024-04-01 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | 開始されました | H.C. Wainwright | Buy |
| 2023-05-17 | 開始されました | Raymond James | Outperform |
| 2023-04-28 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-04-21 | 開始されました | Stifel | Buy |
| 2023-04-20 | 開始されました | Morgan Stanley | Overweight |
| 2023-03-23 | 開始されました | BMO Capital Markets | Outperform |
| 2023-02-28 | 開始されました | SVB Securities | Outperform |
すべてを表示
Disc Medicine Inc (IRON) 最新ニュース
Is Disc Medicine Inc. a good long term investmentExponential return rates - jammulinksnews.com
Disc Medicine Inc. Stock Analysis and ForecastFree AI-Backed Trading Signals - Autocar Professional
What drives Disc Medicine Inc. stock priceJaw-dropping returns - Autocar Professional
What analysts say about Disc Medicine Inc. stockUnrivaled growth potential - Autocar Professional
Disc Medicine’s Strategic Advancements and Regulatory Progress Drive Buy Rating - TipRanks
Disc Medicine To Seek FDA Approval For Bitopertin In EPP, A Painful Sunlight Sensitivity Disorder - Nasdaq
Disc Medicine’s (IRON) “Outperform” Rating Reaffirmed at Wedbush - Defense World
Disc Medicine's NDA Submission for Bitopertin in EPP: A Catalyst-Driven Opportunity in a High-Unmet-Need Market - AInvest
Disc Medicine to submit NDA for bitopertin in EPP in October - Investing.com India
Truist Securities initiates Disc Medicine stock with Buy rating, $86 target - Investing.com Canada
Disc Medicine, Inc. Receives Positive FDA Feedback for Bitopertin NDA Submission in Erythropoietic Protoporphyria - Nasdaq
Disc Medicine Announces Positive Pre-NDA Meeting and - GlobeNewswire
why disc medicine inc. stock attracts strong analyst attentionReal Time Stock Signal - Newser
LifeSci Capital Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $85 - 富途牛牛
Disc Medicine(IRON) Soars 7.28% on Insider Trading, Analyst Rating - AInvest
Disc medicine CFO Franchi sells $119k in shares - Investing.com
Disc medicine CFO Franchi sells $119k in shares By Investing.com - Investing.com India
Raymond James reiterates Strong Buy on Disc Medicine stock amid Bristol Myers trial results - Investing.com Canada
Why Disc Medicine Inc. stock attracts strong analyst attentionMarket Ready Callouts - Newser
How Disc Medicine Inc. stock performs during market volatilityCapital Safe Stock Watchlist - Newser
What makes Disc Medicine Inc. stock price move sharplyRisk Adjusted Stock Signals - Newser
Disc Medicine Elects Nadim Ahmed as Director - The Globe and Mail
Disc Medicine appoints Nadim Ahmed to board of directors - Investing.com Australia
Disc Medicine appoints Nadim Ahmed to board of directors By Investing.com - Investing.com South Africa
Disc medicine CFO Franchi sells $115k in stock By Investing.com - Investing.com Canada
Disc medicine CFO Franchi sells $115k in stock - Investing.com Australia
Disc Medicine, Inc. (NASDAQ:IRON) CEO Sells $1,925,484.00 in Stock - Defense World
Disc Medicine Appoints Nadim Ahmed To Board - citybiz
Disc Medicine Inc (IRON) 財務データ
収益
当期純利益
現金流量
EPS
3.32%
1.57%
大文字化:
|
ボリューム (24 時間):